MPP is a joint venture partnership between the McLaren Healthcare System and our Physician members. Our focus is on providing resources to physician offices which provide value and assist with engagement, clinical integration, contracting and quality.
We are dedicated to our members’ success. It is the reason why our physicians are Michigan’s leaders in care and excellence. Experience the many benefits of MPP membership.
MPP is responsible for the negotiation, development and administration of a variety of managed care contracts for our network of physicians, ancillary facilities and hospitals. We serve as a liaison between the McLaren Healthcare System, health plans, employers, physicians, and patients.
November 15, 2022
Treatment of Vasomotor Symptoms in Menopause
SUMMARY:
Vasomotor and vaginal symptoms are cardinal symptoms of menopause. The occurrence of vasomotor symptoms increases during the transition to menopause and peaks approximately 1 year after the final menstrual period. Systemic estrogen hormone therapy (HT), with or without progestin, is the most effective therapy for menopause-related vasomotor symptoms. Oral and transdermal (i.e., patches, gels, or sprays) estrogen, alone or in combination with progestin, can be used, and have been shown to alleviate vasomotor symptoms.
RECOMMENDATIONS:
RISKS AND BENEFITS:
REFERENCES: